The global medical device cleaning market is expected to grow at a CAGR of around 7.8% from 2020 to 2027 and expected to reach the market value of around US$ 3,765.2 Mn by 2027.
Medical device cleaning necessitates that the device be soiled with biological material in a clinically relevant manner. The soil varies depending on the device being tested, but it is usually a mixture of components, hemoglobin, and carbohydrates. The most commonly used soil for medical device cleaning is Artificial Test Soil (ATS). Furthermore, medical device cleaning is a critical component for overall reprocessing validation, demonstrating that the device can be cleaned in accordance with the manufacturer's instructions for use (IFU). Furthermore, medical device cleaning differs depending on the level of disinfection required, with high level disinfection, intermediate level disinfection, and low level disinfection being the most common.
Automation for medical device cleaning have gained huge market
Manual or automated washers are used to disinfect medical devices. The removal of bio burden and organic residues by the cleaning process is more effective and reproducible when automated cleaning machines are used, according to data revealed by the American Journal of Infection Control. According to a recent study published by Ofstead et al, compliance with endoscope reprocessing guidelines was 1.4 percent for manual cleaning followed by automated disinfection versus 74.5 percent for automated cleaning and disinfection. This is one of the first studies to address the human factors associated with medical device reprocessing flaws. As automation of cleaning ensures reproducibility and efficacy, it is critical to monitor how effective the automated cleaning is over time.
Hospital acquired infections (HAIs) is one of the major factor for the growth of global medical device cleaning market
According to the National Conference of State Legislatures, between 5 and 10% of all patients contract at least one hospital-acquired infection, also known as healthcare-associated infection or nosocomial infection, during their stay in an acute care hospital. HAIs are a major cause of morbidity and mortality in the United States, and they are associated with a significant increase in healthcare costs each year. According to the US Department of Health and Human Services, 1 out of every 25 hospitalized patients in the US is affected by a HAI at any given time. Currently, hospitals are working to prevent or reduce antibiotic resistance in infection-causing bacteria. The Centers for Disease Control and Prevention (CDC) created the Campaign to Prevent Antimicrobial Resistance in Healthcare Settings to disseminate information about preventing bacteria transmission and using antimicrobials wisely. Further, patients with medical devices (central lines, urinary catheters, ventilators) or who undergo surgical procedures are at high risk of acquiring HAIs. Today, HAIs continue to be a tremendous issue; however, most of HAIs are preventable. HAI prevention and management have advanced significantly in the last decade as a result of legislative, regulatory, and organizational incentives.
Imposing stringent regulations by the governing bodies boosts the medical device cleaning market
The State of Queensland (Queensland Health) has revealed that shared patient care equipment that comes into contact with intact skin, such as IV pumps, blood pressure monitors, and wheelchairs, is classified as non-critical under the "Spaulding classification.". Apart from that, specific requirements apply for medical regulation of products intended for use in cleaning and disinfection of medical devices. Cleaners intended for use on medical devices must be registered with the Australian Register of Therapeutic Goods (ARTG) before they can be sold in Australia, and they are classified as a Class I Medical Device. Disinfectants used on medical devices must also be ‘included' in the ARTG and are regulated as a Class IIb Medical Device. Furthermore, according to the Australian guidelines for infection prevention and control in healthcare, local risk assessment should determine the appropriate product, method, and frequency of cleaning of the healthcare environment.
Rising prevalence of surgical site infections (SSIs) boosts the medical device cleaning market
SSIs affect 2% to 4% of all patients undergoing inpatient surgical procedures. Although most infections are treatable with antibiotics, according to the Agency for Healthcare Research and Quality, SSIs continue to be a significant cause of morbidity and mortality after surgery. Furthermore, SSI patients are twice as likely to die, 60% more likely to be admitted to the intensive care unit, and more than five times more likely to be readmitted to the hospital after discharge. The most effective SSI prevention strategies employ a multifaceted approach that includes protocols used before, during, and after surgery to reduce pathogen exposure and susceptibility. Several infection control guidelines and initiatives are available to serve as the foundation for hospital program aimed at lowering the incidence of SSI. The National Healthcare Safety Network (NHSN) of the Centers for Disease Control and Prevention (CDC) has developed SSI measurement standards. The National Surgical Quality Improvement Program (NSQIP) also uses these definitions, though it employs slightly different methods of infection surveillance.
The global medical device cleaning market is segmented as type, device, application, and end-user. By type, the market is segmented as disinfection, automatic cleaning, pre-cleaning, and manual cleaning. By device, the market is segmented as non-critical, critical, and semi-critical. By application, the market is segmented as ultrasound probes, endoscopes, surgical instruments, and other devices. By end-user, the market is segmented as hospitals, ambulatory surgical centers, and others.
By device, semi-critical segment is anticipated to hold dominant market share in the forecast period. Semi-critical devices involve those devices that are exposed to the mucus membranes, such as dental equipment, endoscopes, and other surgical instruments. Due to its multifaceted application, semi-critical segment will dominate the global medical device cleaning market. By application, surgical instrument is expected to record reasonable market share in the forthcoming years. Rising prevalence of burden of HAIs and chronic diseases, rising geriatric population, and surge in number of injuries are the major factors that contribute for the growth of global medical device cleaning market. Based on end-user, hospitals will account largest market share of the medical device cleaning market.
The global medical device cleaning market is dominated by North America. Favorable reimbursement policies and stringent government regulations are driving the growth of the global medical device cleaning market. Asia Pacific, on the other hand, is expected to have the fastest growing CAGR in the coming years. Improvements in healthcare infrastructure and rising medical tourism are driving the growth of the global medical device cleaning market.
The prominent players of the global medical device cleaning market are Steris Corporation, Getinge, Cantel Medical Corporation, Ecolab Inc., ASP(Advanced Sterilization Products), Integra LifeSciences Holdings Corporation, Sklar Surgical Instruments, PAUL HARTMANN AG, and others
Market By Type
Market By Device
Market By Application
Market By End-User
Ambulatory Surgical Centers
Market By Geography
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
Medical device cleaning market is expected to reach a market value of around US$ 3,765.2 Mn by 2027.
The medical device cleaning market is expected to grow at a CAGR of around 7.8% from 2020 to 2027.
Based on device, semi-critical segment is the leading segment in the overall market.
Hospital acquired infections (HAIs) is one of the prominent factors that drive the demand for medical device cleaning market.
Steris Corporation, Getinge, Cantel Medical Corporation, Ecolab Inc., ASP(Advanced Sterilization Products), Integra LifeSciences Holdings Corporation, Sklar Surgical Instruments, PAUL HARTMANN AG, and others.
North America is anticipated to grab the highest market share in the regional market
Asia Pacific is expected to be the fastest growing market in the forthcoming years